Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells

Area of Science:

• Hematology
• Molecular Biology
• Cell Biology

Background:

• Hematopoietic colony-stimulating factors are crucial for blood cell development.
• Leukemia involves abnormal proliferation of hematopoietic cells.
• Understanding growth factors can reveal therapeutic targets for leukemia.

Purpose of the Study:

• To isolate and characterize the gene and product of a human hematopoietic colony-stimulating factor with pluripotent activities.
• To investigate the factor's ability to induce differentiation in leukemia cell lines and patient samples.
• To clone, express, and test the function of recombinant human granulocyte colony-stimulating factor (hG-CSF).

Main Methods:

• Gene cloning and expression in Escherichia coli.
• Colony-forming unit-granulocyte-macrophage (CFU-GM) assays.
• Competitive binding studies using radiolabeled hG-CSF.
• Induction of differentiation in leukemia cell lines and patient cells.

Main Results:

• Recombinant hG-CSF supports neutrophil proliferation and early erythroid/mixed colony formation.
• hG-CSF receptors were identified on murine WEHI-3B(D+) cells and a human ANLL M4 leukemia.
• Recombinant hG-CSF induced terminal differentiation of various human and murine leukemia cells into macrophages and granulocytes.
• The secreted form of hG-CSF is O-glycosylated with a molecular weight of 19,600.

Conclusions:

• hG-CSF is a pluripotent hematopoietic factor with the capacity to induce differentiation in leukemia cells.
• The identification of hG-CSF receptors suggests a direct mechanism of action on target cells.
• Recombinant hG-CSF holds potential for treating certain types of leukemia by promoting cell differentiation.